IDEXX Laboratories (IDXX) Stock Price & Analysis

IDXX$704.23+6.21 +0.89%
Medical - Diagnostics & ResearchLarge CapHigh Quality
Compare
Market cap$55.48BEnterprise value$56.29BRevenue (TTM)$4.66BMarket positionTop 25%

Score

46
Neutral
Value
15
Quality
79
Growth
44

AI Analysis

Snapshot

IDEXX Laboratories scores 46/100, but the multiple is asking a lot (P/E 47.5). Under the hood: P/E 47.5, plus revenue compounding ~9% annually over recent years.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

15
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

44
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

79
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

IDEXX Laboratories, Inc. (IDXX) last printed $704.23. Equity value is $55.48B. Trailing earnings multiple 46.93. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2016201720182019202020212022202320242025
$1.78B$1.97B$2.21B$2.41B$2.71B$3.22B$3.37B$3.66B$3.9B$4.3B

About

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.

IDEXX Laboratories (IDXX) Stock Price & Analysis

IDXX price $704.23 +6.21 +0.89%

Ticker
IDXX
Price
$704.23
Change
+6.21 +0.89%
Market cap
$55.48B
P/E
46.93
Forward P/E
43.25
Dividend yield
0.00%
Beta
1.54
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Stocklytics score
46
Value
15
Quality
79
Growth
44

Stocklytics score rationale: value 15, quality 79, growth 44.

AI Score 75. IDEXX Laboratories, Inc. has strong fundamentals with a net profit margin of 25.4% and a return on equity of 71.2%, indicating efficient profitability

Insights · Forecast · Financials · Learn

Stocklytics home · Screener